ロード中...
Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer
Lung cancer is the most common form of the disease and the leading cause of cancer deaths worldwide. Non-small-cell lung cancer (NSCLC) accounts for approximately 80-85% of all lung cancers. Forty percent of all cases present with stage III, and many of them are considered inoperable (staged IIIA wi...
保存先:
| 出版年: | Transl Lung Cancer Res |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Pioneer Bioscience Publishing Company
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367654/ https://ncbi.nlm.nih.gov/pubmed/25806286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.03.06 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|